Brief: Neogen Announces Sale Of Genomics Business To Zoetis
02/03/2026 14:14
March 2 (Reuters) - Neogen Corp NEOG.O: NEOGEN ANNOUNCES SALE OF GENOMICS BUSINESS TO ZOETIS NEOGEN CORP - ZOETIS TO BUY NEOGEN'S GENOMICS BUSINESS FOR $160 MILLION NEOGEN CORP - PROCEEDS FROM SALE TO BE USED FOR DEBT REDUCTION Source text: ID:nBw2G7Nv3a Further company coverage: NEOG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zoetis
See all newsBrief: Zoetis Receives FDA Approval For Convenia® Rtu For Dogs (Cefovecin Injectable Suspension), Helping More Medium And Large Dogs Access Single-Injection Treatment
Brief: FDA Approves Ready-To-Use Cefovecin Injectable For Treatment Of Certain Skin Infections In Dogs
U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan Materials
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs
Brief: FDA Issues Emergency Use Authorization For Simparica Trio To Treat New World Screwworm In Dogs, Puppies